Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab-3A-interacting protein (RAB3IP) is a guanyl-nucleotide exchange factor (GEF) that promotes the exchange of GDP for GTP on Rab proteins, activating their signaling function[6]. It binds to Rab3A and related small GTPases, catalyzing their transition from an inactive GDP-bound state to an active GTP-bound state, thereby regulating membrane trafficking, vesicle transport, and protein-protein interactions in various cellular processes[1][4][6]. RAB3IP is widely expressed in human tissues, participates in signal transduction and vesicle dynamics, and is associated with cellular compartmentalization, particularly in cytoplasm and cilia[1][3][4]. The molecule is implicated in some human diseases, notably cancer and potentially neurodegenerative conditions, through its regulatory role in vesicle transport and protein trafficking[2][4]. No directly interacting drugs, mechanism-of-action for such agents, specific biomarkers, or safety concerns are robustly described in the provided results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab-3A-interacting protein (RAB3IP).